934176-74-6

Basic information

• Product Name: [5-(3-nitro-phenyl)-thiophen-2-yl]-acetic acid methyl ester
• Synonyms: [5-(3-nitro-phenyl)-thiophen-2-yl]-acetic acid methyl ester
• CAS NO: 934176-74-6
• Molecular Weight: 277.301
• Mol File: 934176-74-6.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: [5-(3-nitro-phenyl)-thiophen-2-yl]-acetic acid methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: [5-(3-nitro-phenyl)-thiophen-2-yl]-acetic acid methyl ester(934176-74-6)
• EPA Substance Registry System: [5-(3-nitro-phenyl)-thiophen-2-yl]-acetic acid methyl ester(934176-74-6)

Safety Data

• Hazardous Substances Data: 934176-74-6(Hazardous Substances Data)

Upstream product

• 19432-68-9 methyl 2-thiopheneacetate 
• 67137-56-8 (5-bromo-thiophen-2-yl)-acetic acid methyl ester 
• 13331-27-6 m-nitrobenzene boronic acid 

Downstream Products

• 934176-77-9 (5-{3-[(2',3',4'-trimethoxy-biphenyl-3-carbonyl)-amino]-phenyl}-thiophen-2-yl)-acetic acid 
• 934176-76-8 (5-{3-[(2',3',4'-trimethoxy-biphenyl-3-carbonyl)-amino]-phenyl}-thiophen-2-yl)-acetic acid methyl ester 
• 934176-75-7 [5-(3-amino-phenyl)-thiophen-2-yl]-acetic acid methyl ester 

Relevant articles and documents

Novel Hydroxylated Aromatic Compounds

Pharmaceutical compositions comprising at least one compound of the formula (I) and a pharmaceutically acceptable carrier which is useful in a medicine wherein the symbols and substituents have the following meaning —X— is e.g. and Y being e.g. or the pharmaceutically acceptable salts, esters or amides and prodrugs can be applied to modulate the in-vitro and in-vivo binding processes mediated by E-, P- or L-selectin binding.

NOVEL PHLOROGLUCINOL DERIVATIVES HAVING SELECTIN LIGAND ACTIVITY

Pharmaceutical compositions comprising at least one compound of the formula (I) and a pharmaceutically acceptable carrier which is useful in a medicine wherein the symbols and substituents have the following meaning -X- is e.g. and Y being e.g. or the pharmaceutically acceptable salts, esters or amides and prodrugs can be applied to modulate the in-vitro and in-vivo binding processes mediated by E-, P- or L-selectin binding.